Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Acasti Pharma Inc.

TRADE

NASDAQ: ACSTHealthcare / Biotechnology / Canada
0.71-0.04-5.33%Vol 151 0351Y Perf -43.66%
Jun 22nd, 2018 15:59
BID0.71 ASK0.72
Open0.75 Previous Close0.75
Pre-Market0.78 After-Trading-
 0.03 4.00%  - -%
Target Price
4.70 
Analyst Rating
Strong Buy 1.00
Potencial %
561.97 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     39.04
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)18 
Earnings Rating
Price Range Ratio 52wk %
3.99 
Earnings Date

Today's Price Range

0.700.77

 

52wk Range

0.603.36

Summary:

Neutral

Technical Indicators: Sell
Moving Averages: Neutral
Performance
1 Month
-1.39%
3 Months
-29.35%
6 Months
-24.47%
1 Year
-43.66%
3 Years
-77.81%
5 Years
-97.39%

Quotes

Name / TickerPriceChg.Chg.%
ACST0.71-0.0400-5.33
AAPL184.92-0.5400-0.29
GOOG1 155.48-2.1800-0.19
MSFT100.41-0.7300-0.72
XOM81.381.69002.12
WFC53.94-0.4300-0.79
JNJ122.841.39001.14
FB201.740.24000.12
GE13.050.29002.27
JPM105.75-1.7600-1.64
...

TickerPriceChg.%52 Week High
KMX80.1912.8681.67
MRO21.487.8322.12
APC74.116.6974.72
PCG42.925.9071.57
PDCO24.625.7648.29
NFX30.755.2035.20
DVN43.285.1845.16
FTI32.345.1435.00
HES64.574.6365.89
PXD185.654.29213.40
XEC97.694.18130.16
COP67.784.1071.71
SWN5.473.806.72
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.60
Current Ratio 2.70
Long Term Debt to Total Capital 0.09
Total Debt to Equity 0.10
Interest Coverage -81.10
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-162.30
EBIT Margin-34 664.40
EBITDA Margin-25 968.80
Pre-tax Profit Margin-7 486.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.19
PS Ratios 22 959.00
Price to Cash Flow -
Price to Free Cash Flow -3.90
Cash Flow Per Share -0.18
Price to Tangible Book7.26
Book Value per Share0.32
Enterprise Value (in ths.)14 765
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-32.28
ROE last 12 Months -94.92
Return on Assets (5Y Avg) -31.34
ROA last 12 Months -68.29
Return on Capital (5Y Avg) -31.80
ROC last 12 Months -40.74
Return on invested Capital Q -36.22
Return on invested Capital Y-21.14
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)1
Revenue per Share 0.00
Revenue Growth 3 Years -77.66
Revenue Growth 5 Years -64.51
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.31-0.310.00
Q01 2017--0.23-
Q04 2016--0.13-
Q03 2016--0.16-
Q02 2016--0.01-
Q01 2016--0.01-
Q04 2015--0.02-
Q03 2015-0.030.03200.00
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.200.00-
3/2018 QR-0.20--
----
----
Next Report Date10th Oct 2017
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume151 035
Shares Outstanding (in ths.)25 600
Trades Count171
Dollar Volume92 897
Avg. Volume301 972
Avg. Weekly Volume240 702
Avg. Monthly Volume249 921
Avg. Quarterly Volume257 061

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

70%30%

Bearish Bullish

63%38%

Bearish Bullish

55%45%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x